Latham & Watkins Advises on Ardent Health Partners' Initial Public Offering

Ardent Health Partners, Inc. (f/k/a Ardent Health Partners, LLC and collectively, Ardent Health) has announced the pricing of its initial public offering of 12,000,000 shares of its common stock at a price to the public of US$16 per share. In connection with the offering, Ardent Health granted the underwriters a 30-day option to purchase up to an additional 1,800,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. The shares began trading on the New York Stock Exchange on July 18, 2024, under the symbol "ARDT" and the offering is expected to close on July 19, 2024, subject to customary closing conditions.

Latham & Watkins LLP represents the underwriters in the offering with a capital markets team led by New York partners Nathan Ajiashvili and Erika Weinberg, and counsel Lindsey Mills, with associates Zoey Wu, Alex Gulino, and Radley Gillis. Advice was also provided on healthcare regulatory matters by Washington, D.C. partners Jason B. Caron and Joseph Hudzik, Boston partner David Tolley, and Washington, D.C. counsel Nicole Liffrig Molife, with associates Margaret Rote, Chad Leiper, and Matt Duffy.